News

New imaging promises improved breast cancer utility


 

EXPERT ANALYSIS FROM IMPAKT 2013 BREAST CANCER CONFERENCE

The conference was sponsored by the European Society for Medical Oncology.

Dr. Pinker-Domenig and Dr. Cook had no disclosures. Dr. de Vries said that she has received grant support from Genentech and Novartis.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

Mammography screening at 75 may have value
MDedge ObGyn
USPSTF draft recommendations update chemoprevention for breast cancer
MDedge ObGyn
Pulsed-dye laser erased evidence of breast radiation
MDedge ObGyn
Supreme Court ponders patenting of human genes
MDedge ObGyn
Smaller margins too close for comfort in breast cancer
MDedge ObGyn
Online cancer community colaunched by ex-Google executive
MDedge ObGyn
Genetic tests gauge breast-cancer recurrence risk
MDedge ObGyn
Cancer-cell reprogramming poses new treatment challenge
MDedge ObGyn
Intratumor heterogeneity drives need for multiple biopsies
MDedge ObGyn
How I screen patients at increased risk for breast cancer
MDedge ObGyn